vs
Side-by-side financial comparison of TechTarget, Inc. (TTGT) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
TechTarget, Inc. is the larger business by last-quarter revenue ($140.7M vs $70.6M, roughly 2.0× Viridian Therapeutics, Inc.\DE). TechTarget, Inc. runs the higher net margin — -6.7% vs -49.0%, a 42.3% gap on every dollar of revenue. TechTarget, Inc. produced more free cash flow last quarter ($11.6M vs $-84.7M).
TechTarget, Inc. is an American company that offers data-driven marketing services to business-to-business technology vendors.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
TTGT vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $140.7M | $70.6M |
| Net Profit | $-9.5M | $-34.6M |
| Gross Margin | 63.8% | — |
| Operating Margin | -10.5% | -56.7% |
| Net Margin | -6.7% | -49.0% |
| Revenue YoY | — | 81958.1% |
| Net Profit YoY | — | 54.9% |
| EPS (diluted) | $-0.09 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $140.7M | — | ||
| Q3 25 | $122.3M | $70.6M | ||
| Q2 25 | $119.9M | — | ||
| Q1 25 | $103.9M | — | ||
| Q3 24 | $62.9M | — |
| Q4 25 | $-9.5M | — | ||
| Q3 25 | $-76.8M | $-34.6M | ||
| Q2 25 | $-398.7M | — | ||
| Q1 25 | $-523.4M | — | ||
| Q3 24 | $-17.4M | — |
| Q4 25 | 63.8% | — | ||
| Q3 25 | 61.3% | — | ||
| Q2 25 | 57.3% | — | ||
| Q1 25 | 57.5% | — | ||
| Q3 24 | 62.1% | — |
| Q4 25 | -10.5% | — | ||
| Q3 25 | -88.2% | -56.7% | ||
| Q2 25 | -342.1% | — | ||
| Q1 25 | -474.5% | — | ||
| Q3 24 | -22.9% | — |
| Q4 25 | -6.7% | — | ||
| Q3 25 | -62.8% | -49.0% | ||
| Q2 25 | -332.4% | — | ||
| Q1 25 | -503.8% | — | ||
| Q3 24 | -27.7% | — |
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $-1.07 | — | ||
| Q2 25 | $-5.58 | — | ||
| Q1 25 | $-7.32 | — | ||
| Q3 24 | $-0.42 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.6M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $594.6M | $503.0M |
| Total Assets | $937.3M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.6M | — | ||
| Q3 25 | $46.3M | $490.9M | ||
| Q2 25 | $61.7M | — | ||
| Q1 25 | $78.7M | — | ||
| Q3 24 | — | — |
| Q4 25 | $594.6M | — | ||
| Q3 25 | $597.9M | $503.0M | ||
| Q2 25 | $668.7M | — | ||
| Q1 25 | $1.1B | — | ||
| Q3 24 | $134.2M | — |
| Q4 25 | $937.3M | — | ||
| Q3 25 | $987.4M | $577.1M | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.5B | — | ||
| Q3 24 | $0 | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.8M | $-84.6M |
| Free Cash FlowOCF − Capex | $11.6M | $-84.7M |
| FCF MarginFCF / Revenue | 8.2% | -120.1% |
| Capex IntensityCapex / Revenue | 0.1% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $15.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.8M | — | ||
| Q3 25 | $-9.1M | $-84.6M | ||
| Q2 25 | $1.5M | — | ||
| Q1 25 | $12.2M | — | ||
| Q3 24 | — | — |
| Q4 25 | $11.6M | — | ||
| Q3 25 | $-9.3M | $-84.7M | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $12.2M | — | ||
| Q3 24 | — | — |
| Q4 25 | 8.2% | — | ||
| Q3 25 | -7.6% | -120.1% | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 11.7% | — | ||
| Q3 24 | — | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.1% | 0.2% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q3 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
